Advanced Search

 

Study ID Status Title Patient Level Data
116952 Completed WEUSKOP6416: Evaluating serious pneumonia in subjects with Chronic Obstructive Pulmonary Disease (COPD) to inform risk minimization: A Retrospective Observational Study
116961 Completed Study DB2116961, A Multicentre, Randomised, Blinded, Parallel Group Study to Compare UMEC/VI (Umeclidinium/Vilanterol) in a Fixed Dose Combination With Indacaterol Plus Tiotropium in Symptomatic Subjects With Moderate to Very Severe COPD Study Listed on ClinicalStudyDataRequest.com
116974 Completed A 12-Week Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared with Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
116975 Completed Population Meta-Pharmacokinetic Analysis of umeclidinium bromide/vilanterol from two Phase III studies (DB2113361, DB2113373) in Adults with Chronic Pulmonary Obstructive Disease (COPD)
116987 Completed A study to evaluate the pharmacokinetics, safety and tolerability, immunogenicity, and pharmacodynamics of GSK2800528 in healthy subjects. Study Listed on ClinicalStudyDataRequest.com
117014 Completed Efficacy, safety and immunogenicity study of GSK Biologicals’ candidate malaria vaccine 257049 in the sporozoite challenge model in healthy malaria-naïve adults
117016 An Open Label Study in Healthy Volunteers to Investigate the Effect of Ketoconazole on the Pharmacokinetics of GSK239512 Study Listed on ClinicalStudyDataRequest.com
117041 Completed A Phase 1, Open-Label, Randomized, Controlled, Four-Period Crossover Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male Volunteers Study Listed on ClinicalStudyDataRequest.com
117115 Completed A multicenter, trial comparing the efficacy and safety of Umeclidinium/Vilanterol 62.5/25 mcg once daily with Tiotropium 18 mcg once daily over 24 weeks in subjects with Chronic Obstructive Pulmonary Disease (COPD). Study Listed on ClinicalStudyDataRequest.com
117156 Completed A randomised, repeat-dose, placebo-controlled, three-way crossover, double dummy study to evaluate and compare the efficacy of Fluticasone Furoate inhalation powder delivered via the single strip dry powder inhaler when administered either in the morning or in the evening, in male and female asthmatic subjects Study Listed on ClinicalStudyDataRequest.com
117170 Active not recruiting Analysis Plan for the Integrated Analysis of Cardiovascular Risk Among Type II Diabetes Subjects Exposed to GSK716155 in the Phase III Program
117211 Completed Plan to Assess the incidence of cardiovascular related adverse events in controlled clinical trials of bupropion for the treatment of smoking cessation
117214 Recruiting Evaluation Of Use of Belimumab in Clinical Practice SEttings (OBSErve) - Observations from Germany
117219 Completed Oral bioavailability study comparing OXEMET™ 1000 mg coated tablets containing metformin hydrochloride with 1000 mg of the reference product (GLAFORNIL™) administered as two 500 mg tablets, through a randomized, single-dose, open label, balanced, 2-way crossover study in healthy volunteers under fasting conditions.OXEMET (TM) is a trademark of the GlaxoSmithKline group of companies. GLAFORNIL(TM) is a trademark of Merck. Study Listed on ClinicalStudyDataRequest.com
117270 Completed A Randomised, Double-Blind (Sponsor-Unblind), Placebo Controlled, Cross-Over Study to Investigate the Efficacy, Effect on Cough Reflex Sensitivity, Safety, Tolerability and Pharmacokinetics of Inhaled GSK2339345 in Patients with Chronic Idiopathic Cough Using an Aqueous Droplet Inhaler Study Listed on ClinicalStudyDataRequest.com
117313 Completed A Single Center, Randomized, Open-Label, Sequential, Single Dose, 4-Period Crossover Study to Evaluate the Bioavailability and Food Effect of a Gelatin Formulation and Two Prototype Formulations of Afuresertib, an AKT Inhibitor, in Normal Healthy Volunteers
117326 Completed A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of 160 mg Enteric-coated Micronised Free Base Darapladib in Healthy Chinese Subjects. Study Listed on ClinicalStudyDataRequest.com
117342 Completed An Evaluation of the Bioequivalence of five 0.1 mg GI198745/dutasteride Soft Gelatin Capsules Compared to one 0.5 mg GI198745/dutasteride Gelatin Capsules in Healthy Male Volunteers Study Listed on ClinicalStudyDataRequest.com
120008/901 Completed A Study to Evaluate the Effect of a High Fiber and a High Fat Meal on the Pharmacokinetics of LANOXIN† (digoxin) Elixir Pediatric in Healthy Adults Study Listed on ClinicalStudyDataRequest.com
134612/003 Completed Assess the safety, reactogenicity, immunogenicity & long-term persistence of one intramuscular dose of GSK Biologicals' MenACWY conjugate vaccine vs one subcutaneous dose of Mencevax™ ACWY in healthy adults aged 18-25 yrs Study Listed on ClinicalStudyDataRequest.com
167-101 Completed GG167 Phase 3 Clinical Trial - Study of prevention effectiveness with respect to influenza virus
167T3-11 Completed Phase III Clinical Study of GG167 -- An open trial of GG167 in the treatment of influenze viral infection in children (open-label study) A survey on time course of influenze-like symptons in pediatric patients with influenze viral infection treated without an influenza antiviral Study Listed on ClinicalStudyDataRequest.com
196131/001 Completed A phase III, partially double blind, randomized, multicentric study to evaluate the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals Kft’s combined DTPwCSL-HB vaccine as compared to Commonwealth Serum Laboratory’s (CSL’s) DTPwCSL (Triple Antigen™) and GSK Biologicals’ HBV (Engerix™-B) administered concomitantly at separate injection sites and to GSK Biologicals’ DTPw-HB vaccine (Tritanrix™-HepB) when administered to healthy infants at 3, 4 and 5 months of age Study Listed on ClinicalStudyDataRequest.com
200065 Completed Glucagon-like peptide-1 (GLP-1) agonists: Treatment utilization patterns and risk of acute pancreatitis
200089 Completed Physician-practice based cohort study to estimate the burden of herpes zoster and postherpetic neuralgia in Japan

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.